We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
ACI
151
AMP Capital Investors
Australia
$173M +$23.7M +234,504 +17%
WT
152
Wellcome Trust
United Kingdom
$173M
MLICM
153
Metropolitan Life Insurance Company (MetLife)
New York
$171M -$7.63M -75,538 -4%
MAMU
154
Marathon Asset Management (UK)
United Kingdom
$171M -$3.15M -31,132 -2%
First Eagle Investment Management
155
First Eagle Investment Management
New York
$170M +$598K +5,915 +0.4%
H
156
Hexavest
Quebec, Canada
$169M +$3.12M +30,873 +2%
Flossbach Von Storch
157
Flossbach Von Storch
Germany
$167M -$22.3M -220,390 -12%
WT
158
Wilmington Trust
Delaware
$164M +$1.92M +18,988 +1%
NFA
159
Nationwide Fund Advisors
Ohio
$163M -$830K -8,208 -0.5%
SB
160
Suntrust Banks
Georgia
$159M -$93.7M -926,849 -38%
Korea Investment Corp
161
Korea Investment Corp
South Korea
$158M +$3.65M +36,100 +2%
Comerica Bank
162
Comerica Bank
Texas
$156M -$23.2M -229,932 -13%
Aviva
163
Aviva
United Kingdom
$155M +$6.01M +59,446 +4%
RFC
164
Regions Financial Corp
Alabama
$154M -$2.28M -22,567 -2%
FMI
165
Factory Mutual Insurance
Massachusetts
$151M +$3.03M +30,000 +2%
AIG
166
American International Group
New York
$150M +$6.52M +64,490 +5%
USSCPF
167
United States Steel & Carnegie Pension Fund
New York
$150M
Hotchkis & Wiley Capital Management
168
Hotchkis & Wiley Capital Management
California
$149M -$253M -2,506,371 -64%
Lord, Abbett & Co
169
Lord, Abbett & Co
New Jersey
$146M +$65.1M +643,783 +85%
VOYA Investment Management
170
VOYA Investment Management
Georgia
$145M +$6.01M +59,454 +4%
TGCM
171
Tukman Grossman Capital Management
California
$142M -$1.3M -12,900 -0.9%
CIBC Private Wealth Group
172
CIBC Private Wealth Group
Georgia
$141M -$2.73M -26,977 -2%
EA
173
Euclid Advisors
Connecticut
$141M -$22M -217,711 -14%
HFS
174
HL Financial Services
Kentucky
$140M -$1.21M -12,017 -0.9%
EIP
175
Epoch Investment Partners
New York
$139M +$8.34M +82,490 +7%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.